Maximus Peto, MBA

Maximus Peto, MBA is Founder/CEO at Invivokines and Biological Researcher at SENS Foundation.
 
Max studies biochemistry, life-extension, transhumanism, politics, economics, efficiency, creativity, and heterologous protein expression. He focuses his effort on extending the maximum, healthy human lifespan. He was previously an accountant and college accounting instructor when he decided to do more to improve the world he lives in, and to encourage others to do the same.
 
Max currently leads the OncoSENS project on alternative lengthening of telomeres (ALT) at the SENSF Research Center. He was recently working on the expression of A2E-degrading enzymes for the SENS Foundation Research Center’s LysoSENS project. A2E is suspected to be the primary cause of age-related macular degeneration, a disease that occurs when the molecule accumulates in the lysosomes of retinal pigment epithelial (RPE) cells in the eye. He optimized growth conditions and media composition for yeast cultures, expressing and purifying A2E-degrading enzymes, performing western blots and activity assays, and purifying A2E that he had previously synthesized.
 
He authored Aluminium and iron in humans: bioaccumulation, pathology, and removal.
 
Max earned his Bachelor of Business Administration (BBA) at University of Toledo in 2004. He earned his Master of Business Administration (MBA) at California State University-Dominguez Hills in 2006. He earned his B.A. in Biochemistry at the University of Toledo in 2010.
 
Read SENS Foundation and Age-Related Macular Degeneration. View his Facebook page. Read his LinkedIn profile.